Asean Health Screening Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2024 –2031 |
 Tamaño del mercado (año base) |
USD 17,697.22 Million |
 Tamaño del mercado (año de pronóstico) |
USD 47,078.82 Million |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
ASEAN Health Screening market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Tests, General Check Up Test, STD's, Blood Pressure Test, and Others), Application (Cardiovascular Disease, Metabolic Disorders, Oncology, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, and Others), Panel Type (Multi-Test Panels, Single-Test Panels), Care/Facility (Integrated, Standalone), User (Domestic User, Medical Tourist), Customer Income (Upper Class, Medium Class, and Lower Class), Provider (Hospitals, Clinics, Nursing Facilities, Rehabilitation Centers, Diagnostic Laboratories, and Others), Countries (India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos) - Industry Trends and Forecast to 2031.
ASEAN Health Screening Market Analysis and Insights
In October 2023, according to the event named as “International Day of Older Persons in Asia and the Pacific, 2023” published on Economic and Social Commission for Asia and the Pacific region. In 2023, an estimated 697 million older persons (60 years or over) are residing in Asia and the Pacific, representing about 60 per cent of all older persons in the world. Roughly one in 7 persons in the region are currently 60 years or older, and by 2050, there will be one in 4 persons belonging to this age cohort. Women account for about 54 per cent of all older women. With increasing age, their share increases. Thus, women account for most of all older persons in the region. Population ageing in Asia and the Pacific is particularly rapid, given the decline in fertility and mortality over recent years. This translates into limited time to prepare for the impacts of ageing on societies.
Data Bridge Market Research analyzes that the Asean health screening market is expected to reach USD 47,078.82 million by 2031 from USD USD 17,697.22 million in 2023, growing at a CAGR of 13.5% in the forecast period of 2024 to 2031.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016–2021) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Test Type (Cholesterol Tests, Diabetes Test, Cancer Tests, General Check Up Test, STD's, Blood Pressure Test, and Others), Application (cardiovascular Disease, Metabolic Disorders, Oncology, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions, and Others), Panel Type (Multi-Test Panels, Single-Test Panels), Care/Facility (Integrated, Standalone), User (Domestic User, Medical Tourist), Customer Income (Upper Class, Medium Class, and Lower Class), Provider (Hospitals, Clinics, Nursing Facilities, Rehabilitation Centers, Diagnostic Laboratories, and Others), Countries (India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma, and Laos) |
|
Countries Covered |
India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos |
|
Market Players Covered |
Fullerton Health Corporation Limited, Mount Alvernia Hospital, PT Prodia Widyahusada Tbk, Raffles Medical Group, and Icon Group, among others |
Market Definition
Health screening is an important tool for detecting a disease early on. Screening tests are frequently used in preventative medicine to determine whether a person displays early indicators of a condition's risk factors. Cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis are all diseases that can be discovered by screening.
This market encompasses a wide range of activities, including routine health check-ups, specialized screenings for chronic diseases such as diabetes, cancer, and cardiovascular conditions, as well as advanced diagnostic procedures. It also involves the use of medical technology and equipment to conduct these tests, and often includes health management programs aimed at promoting overall wellness and early intervention. The health screening market is driven by increasing public awareness of preventive care, advancements in diagnostic technology, and growing demand for personalized healthcare solutions.
ASEAN Health Screening Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Increasing Geriatric Population
The increasing geriatric population in the ASEAN region is a key driver for the health screening market. For example, in 2020, 13.6 percent of the population in Asia and the Pacific is aged 60 years or over, by 2050 it will be one quarter of the population. Health screening plays a crucial role in this context by offering routine check-ups, diagnostic tests, and screenings for various health conditions such as cardiovascular diseases, cancer, diabetes, and respiratory disorders.
While longer lifespans reflect the region’s development success, comprehensive policy reforms are urgently needed to support the welfare of older people, according to Aging Well in Asia: Asian Development Policy Report, released by the Asian Development Bank (ADB) at its 57th Annual Meeting. The number of people aged 60 and older in developing Asia and the Pacific is set to nearly double by 2050 to 1.2 billion—or about a quarter of the total population—significantly increasing the need for pension and welfare programs as well as health care services.
The demand for health screening services is further bolstered by increasing healthcare expenditures, rising disposable incomes, and a growing understanding of the benefits of proactive healthcare management among the aging population in ASEAN. As a result, the health screening market in the region is expected to continue expanding to meet the needs of the increasing geriatric demographic.
Restraint
- High Cost of Healthcare Services
The high cost of health screening services presents a significant restraint for the ASEAN health screening market. Affordability remains a key concern, particularly in low- and middle-income countries where a large portion of the population struggle to access or afford comprehensive health screenings. This economic barrier limits the widespread adoption of preventive healthcare measures and early detection services, hindering efforts to combat the rising burden of chronic diseases in the region. Addressing the issue of high costs requires collaborative efforts from governments, healthcare providers, and private sector entities to develop cost-effective screening solutions, negotiate affordable pricing structures, and implement subsidies or insurance schemes to enhance accessibility for underserved populations.
Opportunity
- Technological Advancements in Health Screening
Innovations in imaging technology, molecular diagnostics, and digital health solutions have revolutionized how diseases are detected and monitored. Technologies such as PCR-based assays, high-resolution imaging techniques, and artificial intelligence-driven analytics have improved the accuracy, speed, and accessibility of health screening tests. This not only benefits healthcare providers by enabling earlier and more precise diagnoses but also empowers patients with better understanding and management of their health.
Moreover, the introduction of these advanced technologies has created a competitive environment where companies strive to differentiate themselves through innovation. These dynamic drives continuous improvement and the development of increasingly sophisticated screening tools, ultimately expanding the overall market for health screening products and services.
Challenge
- Inadequate Quality Assurance and Control
Variations in equipment calibration, maintenance, and operator training can lead to discrepancies in diagnostic accuracy and reliability. Inconsistent calibration schedules or lack of access to calibration services can result in inaccurate readings, affecting diagnosis and treatment outcomes. Additionally, inadequate maintenance due to budget constraints or lack of skilled technicians can cause equipment malfunctions, leading to downtime and unreliable diagnostic results. The proficiency of healthcare providers in operating diagnostic equipment and conducting screening procedures varies widely, and insufficient training along with the lack of standardized protocols can lead to human errors, further compromising the quality and reliability of screenings.
Recent Developments
- In August 2022, Fullerton Health completed merger led by RRJ Capital; Stronger Balance Sheet and New Corporate Structure propelled the post-pandemic growth opportunities. Fullerton Health Corporation Limited (“Fullerton Health” or the “Company”) announced that it had completed a merger led by RRJ Capital (“RRJ”) involving an equity injection by the private equity firm and a senior loan totalling USD 390 million. The merger delivered a stronger balance sheet and a new capital structure which propelled the post-pandemic growth opportunities for the pan-Asian healthcare provider
ASEAN Health Screening Market Scope
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, country. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Test Type
- Cholesterol Tests
- Diabetes Test
- Cancer Tests
- General Check Up Test
- STD's
- Blood Pressure Test
- Others
On the basis of test type, the market is segmented into cholesterol tests, diabetes test, cancer tests, general check up test, STD's, blood pressure test, and others.
Application
- Cardiovascular Disease
- Metabolic Disorders
- Oncology
- Inflammatory Conditions
- Musculoskeletal Disorders
- Neurological Conditions
- Hepatitis-C Complications
- Immunology-Related Conditions
- Others
On the basis of application, the market is segmented into cardiovascular disease, metabolic disorders, oncology, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-c complications, immunology-related conditions, and others.
Panel Type
- Multi-Test Panels
- Single-Test Panels
On the basis of panel type, the market is segmented into multi-test panels and single-test panels.
Care/Facility
- Integrated
- Standalone
On the basis of care/facility, the market is segmented into integrated and standalone.
User
- Domestic User
- Medical Tourist
On the basis of user, the market is segmented into domestic user and medical tourist.
Customer Income
- Upper Class
- Medium Class
- Lower Class
On the basis of customer income, the market is segmented into upper class, medium class, and lower class.
Provider
- Hospitals
- Clinics
- Nursing Facilities
- Rehabilitation Centers
- Diagnostic Laboratories
- Others
On the basis of provider, the market is segmented into hospitals, clinics, nursing facilities, rehabilitation centers, diagnostic laboratories, and others.
ASEAN Health Screening Market Market Regional Analysis/Insights
ASEAN health screening market is segmented into eight notable segments based on test type, application, panel type, care/facility, user, customer income, provider, and country.
The countries covered in this market report is India, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Cambodia, Brunei, Burma and Laos.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and ASEAN Health Screening Market Share Analysis
ASEAN Health Screening market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players operating in the market are Fullerton Health Corporation Limited, Mount Alvernia Hospital, Pt Prodia Widyahusada Tbk., Raffles Medical Group, Icon Group, and The Farrer Park company among others.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASEAN HEALTH SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 ASEAN HEALTH SCREENING MARKET: REGULATIONS
5.1 REGULATIONS IN INDIA:
5.2 REGULATIONS IN SINGAPORE:
5.3 REGULATIONS IN THAILAND:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING GERIATRIC POPULATION
6.1.2 RISING NUMBER OF CHRONIC DISEASES
6.1.3 RISING AWARENESS AMONG PEOPLE FOR HEALTH SCREENING
6.2 RESTRAINTS
6.2.1 HIGH COST OF HEALTHCARE SERVICES
6.2.2 LACK OF TRAINED HEALTHCARE PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING
6.3.2 ACQUISITIONS AND MERGERS AMONG THE MARKET
6.3.3 NEW PRODUCT AND SERVICE LAUNCHES IN THE MARKET
6.4 CHALLENGES
6.4.1 INADEQUATE QUALITY ASSURANCE AND CONTROL
6.4.2 OPERATIONAL BARRIERS IN CONDUCTING SCREENING TESTS
7 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 CHOLESTEROL TESTS
7.2.1 TOTAL CHOLESTEROL TEST
7.2.2 TRIGLYCERIDES
7.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
7.2.4 HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL
7.3 DIABETES TEST
7.3.1 FASTING/RANDOM BLOOD SUGAR TEST
7.3.2 A1C TEST
7.3.3 GLUCOSE TOLERANCE TEST
7.4 CANCER TESTS
7.4.1 LIQUID BIOPSY
7.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI, AND PAP SMEAR TESTS
7.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY
7.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)
7.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST
7.4.6 NEW-EARLY DETECTION CANCER TESTS
7.4.7 ALPHA FETOPROTEIN BLOOD TEST
7.4.8 CA-125 TEST
7.4.9 OTHERS
7.5 GENERAL CHECK UP TEST
7.5.1 REGULAR CHECK UP
7.5.1.1 REGULAR BLOOD TEST
7.5.1.2 X-RAYS
7.5.1.3 ECG
7.5.1.4 FECALYSIS
7.5.1.5 URINALYSIS
7.5.1.6 BMI
7.5.1.7 OTHERS
7.5.2 EYE CHECK UP
7.5.3 DENTAL TEST
7.5.4 HEARING TEST
7.6 STD'S
7.6.1 CHLAMYDIA
7.6.2 GONORRHEA
7.6.3 HPV
7.6.4 HIV
7.6.5 OTHERS
7.7 BLOOD PRESSURE TEST
7.8 OTHERS
7.8.1 LIVER FUNCTION TESTS
7.8.2 KIDNEY PROFILE
8 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE
8.1 OVERVIEW
8.2 MULTI-TEST PANELS
8.3 SINGLE-TEST PANELS
9 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY
9.1 OVERVIEW
9.2 INTEGRATED
9.3 STANDALONE
10 ASEAN HEALTH SCREENING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 CARDIOVASCULAR DISEASE
10.2.1 CORONARY HEART DISEASE
10.2.2 ATHEROSCLEROSIS
10.3 METABOLIC DISORDERS
10.3.1 DIABETES MELLITUS
10.3.2 OBESITY
10.4 ONCOLOGY
10.5 INFLAMMATORY CONDITIONS
10.5.1 AUTOIMMUNE CONDITIONS
10.5.2 ALLERGIES
10.5.3 ARTHRITIS
10.5.4 ASTHMA
10.5.5 INFLAMMATORY DIGESTIVE PROBLEMS
10.6 MUSCULOSKELETAL DISORDERS
10.6.1 OSTEOPOROSIS
10.6.2 RHEUMATOID ARTHRITIS
10.7 NEUROLOGICAL CONDITIONS
10.7.1 CHRONIC STRESS
10.7.2 ALZHEIMER'S DISEASE
11 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME
11.1 OVERVIEW
11.2 UPPER CLASS
11.3 MEDIUM CLASS
11.4 LOWER CLASS
12 ASEAN HEALTH SCREENING MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 NURSING FACILITIES
12.5 REHABILITATION CENTERS
12.6 DIAGNOSTIC LABORATORIES
12.7 OTHERS
13 ASEAN HEALTH SCREENING MARKET, BY USER
13.1 OVERVIEW
13.2 DOMESTIC USER
13.3 MEDICAL TOURIST
14 ASEAN HEALTH SCREENING MARKET, BY COUNTRY
14.1 INDIA
14.2 SINGAPORE
14.3 THAILAND
14.4 MALAYSIA
14.5 INDONESIA
14.6 PHILIPPINES
14.7 VIETNAM
14.8 CAMBODIA
14.9 BRUNEI
14.1 BURMA
14.11 LAOS
15 ASEAN MEDICAL SCREENING MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 FULLERTON HEALTH CORPORATION LIMITED.
17.1.1 COMPANY SNAPSHOT
17.1.2 PRODUCT PORTFOLIO
17.1.3 RECENT DEVELOPMENT
17.2 MOUNT ALVERNIA HOSPITAL.
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENT
17.3 PT PRODIA WIDYAHUSADA TBK.
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 RAFFLES MEDICAL GROUP
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 ICON GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.6 THE FARRER PARK COMPANY
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 PT SILOAM INTERNATIONAL HOSPITALS TBK.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 SINGHEALTH GROUP
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 IHH HEALTHCARE BERHAD
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 LIFESCAN MEDICAL & WELLNESS (A SUBSIDIARY OF SINGAPORE MEDICAL GROUP LIMITED)
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 MANADR PTE LTD.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 NATIONAL UNIVERSITY HEALTH SYSTEM.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PT MEDIKA LOKA MANAJEMEN
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 ROYAL HEALTHCARE
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 ROYAL PHNOM PENH HOSPITAL
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 KALBE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Lista de Tablas
TABLE 1 ASEAN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 2 ASEAN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 3 ASEAN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASEAN CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 5 ASEAN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 6 ASEAN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 7 ASEAN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 8 ASEAN OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 9 ASEAN HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 10 ASEAN HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)..
TABLE 11 ASEAN HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 12 ASEAN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 ASEAN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 14 ASEAN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 ASEAN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 16 ASEAN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 ASEAN HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 18 ASEAN HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 19 ASEAN HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 20 ASEAN HEALTH SCREENING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 21 INDIA HEALTH SCREENING MARKET, BY CITY, 2022-2031 (USD MILLION)
TABLE 22 INDIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 23 INDIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 24 INDIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 25 INDIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 26 INDIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 27 INDIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 28 INDIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 29 INDIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 30 INDIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 31 INDIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 INDIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 INDIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 34 INDIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 35 INDIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 INDIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 37 INDIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 38 INDIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 39 INDIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 40 INDIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 41 SINGAPORE HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)..
TABLE 42 SINGAPORE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 43 SINGAPORE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 44 SINGAPORE CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 45 SINGAPORE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 46 SINGAPORE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 47 SINGAPORE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 48 SINGAPORE OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 49 SINGAPORE HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 SINGAPORE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 SINGAPORE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 SINGAPORE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 SINGAPORE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 SINGAPORE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 SINGAPORE HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 56 SINGAPORE HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 57 SINGAPORE HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 58 SINGAPORE HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 59 SINGAPORE HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 60 THAILAND HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 61 THAILAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 62 THAILAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 63 THAILAND CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 64 THAILAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 65 THAILAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 66 THAILAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 67 THAILAND OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 68 THAILAND HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 69 THAILAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 70 THAILAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 THAILAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 THAILAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 THAILAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 THAILAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 75 THAILAND HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 76 THAILAND HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 77 THAILAND HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 78 THAILAND HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 79 MALAYSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 80 MALAYSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 81 MALAYSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 82 MALAYSIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 83 MALAYSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 84 MALAYSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 85 MALAYSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 86 MALAYSIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 87 MALAYSIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 88 MALAYSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 MALAYSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 MALAYSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 MALAYSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 MALAYSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 MALAYSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)..
TABLE 94 MALAYSIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 95 MALAYSIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 96 MALAYSIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 97 MALAYSIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 98 INDONESIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 99 INDONESIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 100 INDONESIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 101 INDONESIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 102 INDONESIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 103 INDONESIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 104 INDONESIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 105 INDONESIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 106 INDONESIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 107 INDONESIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 INDONESIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 INDONESIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 INDONESIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 INDONESIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 INDONESIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 113 INDONESIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 114 INDONESIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 115 INDONESIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 116 INDONESIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 117 PHILIPPINES HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 118 PHILIPPINES CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 119 PHILIPPINES DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 120 PHILIPPINES CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 121 PHILIPPINES GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 122 PHILIPPINES REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 123 PHILIPPINES STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 124 PHILIPPINES OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 125 PHILIPPINES HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 126 PHILIPPINES CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 127 PHILIPPINES METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 PHILIPPINES INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 PHILIPPINES MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 PHILIPPINES NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 PHILIPPINES HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 132 PHILIPPINES HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 133 PHILIPPINES HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 134 PHILIPPINES HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 135 PHILIPPINES HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 136 VIETNAM HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 137 VIETNAM CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 138 VIETNAM DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 139 VIETNAM CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 140 VIETNAM GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 141 VIETNAM REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 142 VIETNAM STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 143 VIETNAM OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 144 VIETNAM HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)..
TABLE 145 VIETNAM CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 VIETNAM METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 VIETNAM INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 VIETNAM MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 VIETNAM NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 VIETNAM HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 151 VIETNAM HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 152 VIETNAM HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 153 VIETNAM HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 154 VIETNAM HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 155 CAMBODIA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)…
TABLE 156 CAMBODIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 157 CAMBODIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 158 CAMBODIA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 159 CAMBODIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 160 CAMBODIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 161 CAMBODIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 162 CAMBODIA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 163 CAMBODIA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 164 CAMBODIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 CAMBODIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 CAMBODIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 CAMBODIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 168 CAMBODIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 CAMBODIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 170 CAMBODIA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 171 CAMBODIA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 172 CAMBODIA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 173 CAMBODIA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)..
TABLE 174 BRUNEI HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 175 BRUNEI CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 176 BRUNEI DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 177 BRUNEI CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 178 BRUNEI GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 179 BRUNEI REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 180 BRUNEI STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 181 BRUNEI OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 182 BRUNEI HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 183 BRUNEI CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 BRUNEI METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 185 BRUNEI INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 BRUNEI MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 BRUNEI NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 BRUNEI HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 189 BRUNEI HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 190 BRUNEI HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 191 BRUNEI HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 192 BRUNEI HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 193 BURMA HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 194 BURMA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 195 BURMA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 196 BURMA CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 197 BURMA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 198 BURMA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 199 BURMA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 200 BURMA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 201 BURMA HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 202 BURMA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 BURMA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 BURMA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 BURMA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 206 BURMA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 BURMA HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 208 BURMA HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 209 BURMA HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 210 BURMA HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 211 BURMA HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
TABLE 212 LAOS HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 213 LAOS CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 214 LAOS DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 215 LAOS CANCER TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 216 LAOS GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 217 LAOS REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 218 LAOS STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 219 LAOS OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)
TABLE 220 LAOS HEALTH SCREENING MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 221 LAOS CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 222 LAOS METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 LAOS INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 LAOS MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 225 LAOS NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 226 LAOS HEALTH SCREENING MARKET, BY PANEL TYPE, 2022-2031 (USD MILLION)
TABLE 227 LAOS HEALTH SCREENING MARKET, BY CARE/FACILITY, 2022-2031 (USD MILLION)
TABLE 228 LAOS HEALTH SCREENING MARKET, BY USER, 2022-2031 (USD MILLION)
TABLE 229 LAOS HEALTH SCREENING MARKET, BY CUSTOMER INCOME, 2022-2031 (USD MILLION)
TABLE 230 LAOS HEALTH SCREENING MARKET, BY PROVIDER, 2022-2031 (USD MILLION)
Lista de figuras
FIGURE 1 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 2 ASEAN HEALTH SCREENING MARKET: DATA TRIANGULATION
FIGURE 3 ASEAN HEALTH SCREENING MARKET: DROC ANALYSIS
FIGURE 4 ASEAN HEALTH SCREENING MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 ASEAN HEALTH SCREENING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASEAN HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASEAN HEALTH SCREENING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASEAN HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASEAN HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASEAN HEALTH SCREENING MARKET: SEGMENTATION
FIGURE 11 SEVEN SEGMENTS COMPRISE THE ASEAN HEALTH SCREENING MARKET, BY TEST TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DEVELOPMENTS
FIGURE 14 RISING NUMBER OF CHRONIC DISEASES IS DRIVING THE GROWTH OF THE ASEAN HEALTH SCREENING MARKET FROM 2024 TO 2031
FIGURE 15 THE CHOLESTEROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASEAN HEALTH SCREENING MARKET IN 2024 AND 2031
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASEAN HEALTH SCREENING MARKET
FIGURE 17 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2023
FIGURE 18 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)
FIGURE 19 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 20 ASEAN HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 21 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2023
FIGURE 22 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, 2024-2031 (USD MILLION)
FIGURE 23 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2024-2031)
FIGURE 24 ASEAN HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE
FIGURE 25 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2023
FIGURE 26 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, 2024-2031 (USD MILLION)
FIGURE 27 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, CAGR (2024-2031)
FIGURE 28 ASEAN HEALTH SCREENING MARKET: BY CARE/FACILITY, LIFELINE CURVE
FIGURE 29 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2023
FIGURE 30 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 31 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 32 ASEAN HEALTH SCREENING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 33 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2023
FIGURE 34 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, 2024-2031 (USD MILLION)
FIGURE 35 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, CAGR (2024-2031)
FIGURE 36 ASEAN HEALTH SCREENING MARKET: BY CUSTOMER INCOME, LIFELINE CURVE
FIGURE 37 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2023
FIGURE 38 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, 2024-2031 (USD MILLION)
FIGURE 39 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, CAGR (2024-2031)
FIGURE 40 ASEAN HEALTH SCREENING MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 41 ASEAN HEALTH SCREENING MARKET: BY USER, 2023
FIGURE 42 ASEAN HEALTH SCREENING MARKET: BY USER, 2024-2031 (USD MILLION)
FIGURE 43 ASEAN HEALTH SCREENING MARKET: BY USER, CAGR (2024-2031)
FIGURE 44 ASEAN HEALTH SCREENING MARKET: BY USER, LIFELINE CURVE
FIGURE 45 ASEAN HEALTH SCREENING MARKET: SNAPSHOT, 2023
FIGURE 46 ASEAN MEDICAL SCREENING MARKET: COMPANY SHARE 2023 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
